Organization
Dartmouth Hitchcock Medical Center, Lebanon
1 abstract
Abstract
AN OPEN-LABEL STUDY OF THE SAFETY OF RITUXIMAB (RTX) IN COMBINATION WITH OTHER BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA) Org: Dartmouth Hitchcock Medical Center, Lebanon, Swedish Rheumatology Associates, Seattle, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States of America, Genentech, South San Francisco, United States,